BCL2L11 and acute myeloid leukemia: These results are consistent with the idea that RSK1 may promote degradation of BIM-EL phosphorylated on S69 by ERK in FLT3-ITD-positive AML cells, which may play an anti-apoptotic role by reducing this pro-apoptotic member of the Bcl-2 family.